The impact of admission procalcitonin on prognosis in acute coronary syndromes: a pilot study

Author： Picariello Claudio   Lazzeri Chiara   Attanà Paola   Chiostri Marco   Gensini Gian Franco   Valente Serafina  

Publisher： Informa Healthcare

ISSN： 1366-5804

Source： Biomarkers, Vol.17, Iss.1, 2012-02, pp. : 56-61

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Apoptosis and oncosis in acute coronary syndromes: Assessment and implications

By Jugdutt Bodh   Idikio Halliday  

Molecular and Cellular Biochemistry, Vol. 270, Iss. 1-2, 2005-02 ,pp. : 177-200

Springer Publishing Company

Access to resources Recommend Favorite

Characterization and metal affinity of Tirofiban, a pharmaceutical compound used in acute coronary syndromes

By Ferrari E.   Menabue L.   Saladini M.  

BioMetals, Vol. 17, Iss. 2, 2004-04 ,pp. : 145-155

Springer Publishing Company

Access to resources Recommend Favorite

Risk stratification and short-term prognosis in acute heart failure syndromes: A review of novel biomarkers

By Avellino Ariadne   Collins Sean P.   Fermann Gregory J.  

Biomarkers, Vol. 16, Iss. 5, 2011-08 ,pp. : 379-392

Informa Healthcare

Access to resources Recommend Favorite

Procalcitonin as a prognostic marker in patients with acute myocardial infarction

By Kelly Dominic   Khan Sohail Q.   Dhillon Onkar   Quinn Paulene   Struck Joachim   Squire Iain B.   Davies Joan E.   Ng Leong L.  

Biomarkers, Vol. 15, Iss. 4, 2010-06 ,pp. : 325-331

Informa Healthcare

Access to resources Recommend Favorite

Serum metabolomics reveals lipid metabolism variation between coronary artery disease and congestive heart failure: a pilot study

By Luan Hemi  

Biomarkers, Vol. 18, Iss. 4, 2013-06 ,pp. : 314-321

Informa Healthcare

Access to resources Recommend Favorite